No association between dupilumab use and short-term cancer development in atopic dermatitis patients

J Allergy Clin Immunol Pract. 2023 May;11(5):1548-1551. doi: 10.1016/j.jaip.2022.12.018. Epub 2022 Dec 26.

Affiliations

¹ Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY.
² A. T. Still University, Kirksville, Mo.
³ Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY. Electronic address: nicholas.gulati@mssm.edu.

PMID: 36581076
DOI: 10.1016/j.jaip.2022.12.018

No abstract available

MeSH terms

Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized / therapeutic use
Dermatitis, Atopic* / drug therapy
Dermatitis, Atopic* / epidemiology
Humans
Neoplasms*
Severity of Illness Index
Treatment Outcome

Substances

dupilumab
Antibodies, Monoclonal, Humanized
Antibodies, Monoclonal